Optimization, ex vivo permeation, and stability study of lipid nanocarrier loaded gelatin capsules for treatment of intermittent claudication

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 4459-4478

  Sallam, Marwa Ahmed ^a   Boscá, María Teresa Marín ^b  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Butyl lactate; Cilostazol; Desirability; Preconcentrates; Solubilisant Gamma

Indexed keywords

AEROSIL; CILOSTAZOL; DIETHYLENE GLYCOL MONOETHYL ETHER; GELATIN; LIPID; NANOCARRIER; NANOPARTICLE; SURFACTANT; DRUG CARRIER; EMULSION; TETRAZOLE DERIVATIVE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG METABOLISM; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; EMULSION; EX VIVO STUDY; IN VITRO STUDY; INTERMITTENT CLAUDICATION; MALE; MEMBRANE TRANSPORT; MICROCAPSULE; NANOEMULSION; NONHUMAN; PRECIPITATION; PROCESS OPTIMIZATION; RAT; TABLET FORMULATION; CHEMISTRY; MEDICINAL CHEMISTRY; PROCEDURES;

CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG STABILITY; EMULSIONS; GELATIN; LIPIDS; NANOPARTICLES; TETRAZOLES; VASODILATOR AGENTS;

EID: 84937598313     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S83123     Document Type: Article

References (33)

1. Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413–420.
2. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58:173–182.
3. Porter CJH, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev. 2008;60:673–691.
4. Mueller RH, Maeder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery: a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161–177.
5. Kawakami K, Yoshikawa T, Morto Y, et al. Microemulsion formulation for enhanced absorption of poorly soluble drugs I. Prescription design. J Control Rel. 2002;81:65–74.
6. Kossena GA, Charman WN, Boyd BJ, Dunstan DE, Porter CJH. Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid based delivery systems: a phase diagram approach. Pharm Sci. 2004;93:332–348.
7. Franceschinis E, Voinovich D, Grassi M, et al. Self-emulsifying pellets prepared by wet granulation in high-shear mixer: influence of formulation variables and preliminary study on the in vitro absorption. Int J Pharm. 2005;291:87–97.
8. Yi T, Wan J, Xu H, Yang X. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur J Pharm Biopharm. 2008;70:439–444.
9. Nazzal S, Smalyukh I, Lavrentovich OD, Khan MA. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int J Pharm. 2002;235:247–265.
10. Maruyama H, Fukuoka T, Deguchi I, et al. Dual antiplatelet therapy clopidogrel with low-dose cilostazol intensifies platelet inhibition in patients with ischemic stroke. Intern Med. 2013;52(10):1043–1047.
11. Bramer SL, Forbes WP. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics. Clin Pharmacokinet. 1999;37:13–23.
12. Xiaoqing M, Changshan S, Tongying J, Li Z, Tianyi W, Siling W. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol. J Pharm Pharm Sci. 2011;14:196–214.
13. Samir GP, Sadhana JR. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes. AAPS Pharm Sci Tech. 2009;10:660–669.
14. Mahmoud DB, Shukr MH, Bendas ER. In vitro and in vivo evaluation of self-nanoemulsifying drug delivery systems of cilostazol for oral and parenteral administration. Int J Pharm. 2014;476:60–69.
15. Zidan AS, Sammour OA, Hammad MA, Megrab NA, Habib MJ, Khan MA. Quality by design: understanding the product variability of a self nanoemulsifying drug delivery system of cyclosporine A. J Pharm Sci. 2007;96:2409–2423.
16. Liu Y, Zhang P, Feng N, Zhang X, Wu S, Zhao J. Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin. Int J Pharm. 2009;365:136–142.
17. Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm. 2007;329:166–172.
18. Huang YB, Tsai Y, Lee SH, Chang JS, Wu PC. Optimization of pH independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int J Pharm. 2005;289:87–95.
19. Mahmoud EA, Bendas ER, Mohamed MI. Preparation and evaluation of self nanoemulsifying tablets of carvedilol. AAPS Pharm Sci Tech. 2009;10:183–192.
20. Dixit RP, Nagarsenker MS. Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation. Eur J Pharm Sci. 2008;35:183–192.
21. Zhao Y, Wang C, Chow AHL, et al. Self nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: Formulation and bioavailability studies. Int J Pharm. 2010;383:170–177.
22. Shafiq S, Shakeel F, Talegaonka, S, Ahmad FJ, Khar RK, Ali M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007;66:227–243.
23. Rane SS, Anderson BD. What determines drug solubility in lipid vehicles: is it predictable. Adv Drug Deliv Rev. 2008;60:638–656.
24. Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I:Development and optimization. Int J Pharm. 2010;391:203–211.
25. Rao SV, Shao J.: Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development. Int J Pharm. 2008;362:2–9.
26. Nepal PR, Han H, Choi H. Preparation and in vitro–in vivo evaluation of Witepsol® H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q10. Eur J Pharm Sci. 2010;39:224–232.
27. Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of Coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm. 2001;212:233–246.
28. Borhade V, Nair H, Hegde D. Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus. AAPS Pharm Sci Tech. 2008;9:13–21.
29. Li P, Ghosh A, Wagner RF, Krill S, Joshi YM, Serajuddin ATM. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int J Pharm. 2005;288:27–34.
30. Pund S, Shete Y, Jagadale S. Multivariate analysis of physicochemical characteristics of lipid based nanoemulsifying cilostazol-quality by design. Colloids Surf B Biointerfaces. 2014;115:29–36.
31. Wang L, Dong J, Chen J, Eastoe J, Li X. Design and optimization of new self nanoemulsifying drug delivery system. J Colloid Interface Sci. 2009;330:443–448.
32. Chen Y, Li G, Wu X, et al. Self microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment. Biol Pharm Bull. 2008;31:118–125.
33. Le Ferrec E, Chesne C, Artusson P, et al. In vitro models of the intestinal barrier. The report and recommendations of ECVAM Workshop 46. European Centre for the Validation of Alternative methods. Altern Lab Anim. 2001;29:649–668.